FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

CMS Working with FDA on New Device Coverage Rule

Two Centers for Medicare and Medicaid Services officials describe the principles in a new coverage rule for innovative medical devices the agency is d...

latest-news-card-1
Human Drugs

Exela Pharma Recalls 49 Sodium Bicarbonate Lots

Exela Pharma Sciences (Lenoir, NC) recalls 49 lots of sodium bicarbonate injection due to safety concerns.

latest-news-card-1
Human Drugs

FDA Revamping NDA/BLA Information Requests

FDA seeks public comments on a Statement of Work mandated by the recent drug user fee reauthorization to assess communication between the agency and s...

latest-news-card-1
Human Drugs

Three Charged with Falsifying Clinical Trial Data

A Miami grand jury charges three defendants for their roles in an alleged scheme to fabricate and falsify clinical drug trial data submitted to FDA.

latest-news-card-1
Human Drugs

FDA Publishes ICH E19 Guideline

FDA publishes the International Council for Harmonization E19 guideline on selective safety data collection in some circumstances.

latest-news-card-1
Human Drugs

FDA Seeks Covis Info for Makena Hearing

CDER asks an FDA hearing officer to direct Covis to provide additional information on items from its final briefing materials for an upcoming hearing ...

Biologics

GSK Respiratory Syncytial Virus Vaccine Highly Efficacious

GlaxoSmithKline says its investigational adult respiratory syncytial virus vaccine candidate was highly effective in a Phase 3 trial, with a favorable...

latest-news-card-1
Human Drugs

FDA Says Adderall is in Shortage

FDA says Teva manufacturing delays have led to a shortage of Adderalls immediate-release formulation.

latest-news-card-1
Human Drugs

CMC Comparability Protocol Guidance

FDA publishes a final guidance on using comparability protocols for postapproval changes in chemistry, manufacturing, and controls information in NDAs...

latest-news-card-1
Human Drugs

Distributed Manufacturing Discussion Paper

FDA solicits input on a discussion paper raising regulatory issues and questions about direct manufacturing and point-of-care manufacturing of drugs.